undamentalytics Newsletter

Doximity, Inc. income statement

In fiscal 2026, Doximity, Inc. reported revenue of $645m, up 13.1% on the year before, operating income of $215m (a 33.3% margin) and net income of $196m, or $0.98 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Doximity, Inc.: income statement, annual
Fiscal year2020Mar 20202021Mar 20212022Mar 20222023Mar 20232024Mar 20242025Mar 20252026Mar 2026LTMJun 2026
Revenue116207344419475570645656
Cost of revenue1531405351567078
Gross profit101176304366425515575577
Research and development324462808293131142
Selling and marketing396292124133146164172
General and administrative716363738466569
Operating income2253114125164228215194
Income before tax2458114133185264250226
Income tax−68−412038405459
Net income3050155113148223196167
Diluted EPS$0.07$0.12$0.70$0.53$0.72$1.11$0.98$0.85
Diluted shares (average)163m190m191m213m206m201m199m197m
EBITDA2357119135174238229206

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: DOCS vs GDRXDOCS vs PHRDOCS vs WGS

More: Health Care Technology stocks compared, Health Care sector, rankings of US companies

Figures from Doximity, Inc.'s SEC filings (10-K and 10-Q), retrieved October 20, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Doximity, Inc.